3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
6
Myelodysplastic Syndromes
4
Lymphoma
3
Leukemia
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Thalassemia
1
Sezary Syndrome
1
Recurrence
1
Pseudomyxoma Peritonei
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
pembrolizumab
16
Bevacizumab
11
Carboplatin
10
Nivolumab
8
Pemetrexed
7
Temozolomide
6
atezolizumab
5
Standard of Care
5
Prednisone
5
Exercise
5
Cyclophosphamide
5
Cetuximab
5
durvalumab
4
abemaciclib
4
Paclitaxel
4
Dexamethasone
4
Cisplatin
4
Blood Specimen Collection
4
dostarlimab
3
daratumumab
3
cabozantinib
3
Rituximab
3
Oxaliplatin
3
Metformin
3
Leucovorin
3
Lenalidomide
3
Ipilimumab
3
Fluorouracil
3
Doxorubicin
3
Docetaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Tacrolimus
×
30 days
×
Clear all
No trials found.